CannPal Animal Therapeutics Limited (CP1.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.1800-0.0050 (-2.70%)
At close: 3:54PM AEDT
Loading interactive chart…
- ABN Newswire
AusCann Group Holdings Ltd (AC8.AX) and CannPal Enter Into Scheme of Arrangement
AusCann Group Holdings Ltd (ASX:AC8), an Australian based pharmaceutical company focused on the development, production and distribution of cannabinoid-based medicines within Australia and internationally, is pleased to announce that it has entered into a scheme implementation deed (SID) with CannPal Animal Therapeutics Limited.
- Simply Wall St.
Key Things To Understand About CannPal Animal Therapeutics' (ASX:CP1) CEO Pay Cheque
The CEO of CannPal Animal Therapeutics Limited (ASX:CP1) is Layton Mills, and this article examines the executive's...
- Simply Wall St.
Is CannPal Animal Therapeutics (ASX:CP1) In A Good Position To Invest In Growth?
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
© 2021 Verizon Media. All rights reserved.
